Kraton Corporation Announces Third Quarter 2016 Results

Mittwoch, 26.10.2016 23:50 von

PR Newswire

HOUSTON, Oct. 26, 2016 /PRNewswire/ -- Kraton Corporation (NYSE: KRA), a leading global producer of styrenic block copolymers, specialty polymers, and value-added specialty products primarily derived from renewable sources, announces financial results for the quarter ended September 30, 2016.

2016 THIRD QUARTER HIGHLIGHTS

  • Strong volume growth for the Polymer segment, with sales volume up 6.1% compared to the third quarter 2015. Sales volume in our Chemical segment was in line with third quarter 2015.
  • Net income was $15.6 million, or $0.49 per diluted share, in the third quarter 2016 compared to a net income of $8.4 million, or $0.27 per diluted share, in the third quarter 2015. Adjusted earnings per diluted share (non-GAAP) was $0.63 in the third quarter 2016 compared to $0.48 in the third quarter 2015.
  • Adjusted EBITDA (non-GAAP) was $91.1 million in the third quarter 2016 compared to $42.4 million in the third quarter 2015.
  • Realized $10.9 million of year-over-year benefit associated with integration synergies and cost reduction initiatives in the third quarter 2016.


Three Months Ended September 30,



Nine Months Ended September 30,



2016



2015



2016



2015



(In thousands, except per share amounts)

Revenue

$

454,143





$

269,012





$

1,328,715





$

786,349



Net income (loss) attributable to Kraton

$

15,560





$

8,446





$

111,048





$

(6,574)



Adjusted EBITDA (non-GAAP)(1)

$

91,074





$

42,393





$

276,911





$

116,773



Adjusted EBITDA as % of revenue (non-GAAP)

20.1

%



15.8

%



20.8

%



14.9

%

Earnings (loss) per diluted share

$

0.49





$

0.27





$

3.56





$

(0.21)



Adjusted earnings per diluted share (non-GAAP)(1)

$

0.63





$

0.48





$

2.07





$

1.26





_______________________

(1)

See non-GAAP reconciliations included in the accompanying financial tables for the reconciliation of each non-GAAP measure to its most directly comparable GAAP measure.

 

"During the third quarter 2016 we continued to execute under our cost reduction initiatives and we delivered solid progress toward achieving our targeted transaction synergies for the year. With regard to our HSBC project in Mailiao, Taiwan, having previously achieved mechanical completion, during the quarter the plant was undergoing steps in the commissioning phase as we move toward anticipated commercial production before year end. With respect to our CariflexTM 'direct-couple' project in Paulinia, Brazil, during the third quarter we conducted an extremely successful preliminary production run on the commercial asset that further validates our expectations for the benefits of our new process technology," said Kevin M. Fogarty, Kraton's President and Chief Executive Officer. "We still expect to deliver $70 million of cost reductions and $65 million of transaction synergies by year-end 2018."

"Overall, our results for the third quarter 2016 were below our expectations principally due to incremental margin pressure in our adhesives businesses, lower than planned sales of SBS into paving applications and the impact of lower pricing for TOFA in our Chemical Intermediates business," said Fogarty. "During the quarter our Polymer segment remained on its trend of volume growth, and sales mix improvement. Our Cariflex business continued to demonstrate its attractive market value, as evidenced by 29% volume growth, and we realized 10% volume growth for our Specialty Polymer HSBC product grades, compared to the third quarter 2015. Despite lower than expected sales of SBS grades into paving applications related to a supply constraint for butadiene and production shortfalls in the quarter, sales volume for Performance Products was up over 3% compared to Q3 2015. Differentiated sales as a percentage of the Polymer segment sales mix, increased to 60% in the TTM period ending September 30, 2016, up from 59% for the period ending June 30, 2016," added Fogarty.

"During the quarter, continued availability of low-cost, C5-hydrocarbon-based resins maintained pressure on margins for certain adhesive products in our Chemical segment. In addition, our Chemical Intermediates business experienced continued margin pressure, resulting from the on-going over-supply of TOFA, the impact of increased energy prices on our feedstock costs, and to a lesser extent, changes in product mix. Nevertheless, despite these pressures, in the third quarter 2016 our Chemical segment generated $22.1 million in operating income and $41.5 million in Adjusted EBITDA, resulting in  Adjusted EBITDA as a percentage of revenue for the segment of 23%, reflecting its resiliency and attractive customer value" said Fogarty.

Status of Synergies, Operational Improvement, and Cost Reduction Initiatives

We previously announced synergies and operational improvement initiatives associated with our January 6, 2016 acquisition of Arizona Chemical (the "Arizona Chemical Acquisition") and a cost reduction initiative targeted at lowering costs in our Polymer segment. Following is a summary of the status of these initiatives:



Three Months Ended September 30,



Nine Months Ended September 30,







2016



2015



Incremental



2016



2015



Incremental



Cumulative(1)



(In thousands)

G&A synergies

$

5,099





$





$

5,099





$

10,722





$





$

10,722





$

10,722



Operational improvements

4,224









4,224





9,631









9,631





9,631



Polymer cost reduction

6,888





5,279





1,609





20,242





11,859





8,383





27,771





$

16,211





$

5,279





$

10,932





$

40,595





$

11,859





$

28,736





$

48,124





___________________________________

(1)

The cumulative Polymer cost reduction initiatives include $19.4 million realized in the full year 2015.

 

Consolidated Results

Q3 2016 VERSUS Q3 2015 RESULTS

Revenue was $454.1 million for the three months ended September 30, 2016 compared to $269.0 million for the three months ended September 30, 2015, an increase of $185.1 million or 68.8%, of which $181.2 million relates to our Chemical segment.

Gross profit was $135.3 million for the three months ended September 30, 2016 compared to $67.8 million for the three months ended September 30, 2015, an increase of $67.4 million or 99.5%, of which $58.2 million relates to our Chemical segment.

Research and development expenses were $9.7 million for the three months ended September 30, 2016 compared to $7.6 million for the three months ended September 30, 2015, an increase of $2.1 million or 27.6%, of which $2.8 million related to our Chemical segment. 

Selling, general, and administrative expenses were $42.8 million for the three months ended September 30, 2016 compared to $26.9 million for the three months ended September 30, 2015, an increase of $15.9 million or 58.9%, of which $16.4 million relates to our Chemical segment.

Interest expense, net was $33.9 million for the three months ended September 30, 2016 compared to $6.2 million for the three months ended September 30, 2015, an increase of $27.7 million. The increase is primarily due to additional indebtedness related to the Arizona Chemical Acquisition.

Income tax expense was $2.2 million and $3.1 million for the three months ended September 30, 2016 and 2015, respectively.

Net income attributable to Kraton was $15.6 million or $0.49 per diluted share for the three months ended September 30, 2016, an increase of $7.1 million compared to net income of $8.4 million or $0.27 per diluted share for the three months ended September 30, 2015. Adjusted earnings per diluted share (non-GAAP) was $0.63 for the three months ended September 30, 2016 compared to $0.48 for the three months ended September 30, 2015. See a reconciliation of U.S. generally accepted accounting principles ("GAAP") earnings (loss) per diluted share to non-GAAP adjusted earnings per diluted share below.

YTD 2016 VERSUS YTD 2015 RESULTS

Revenue was $1,328.7 million for the nine months ended September 30, 2016 compared to $786.3 million for the nine months ended September 30, 2015, an increase of $542.4 million or 69.0%, of which $542.6 million relates to our Chemical segment.

Gross profit was $361.0 million for the nine months ended September 30, 2016 compared to $161.8 million for the nine months ended September 30, 2015. The increase includes gross profit of $151.2 million from our Chemical segment, which includes $24.7 million of higher costs of goods sold related to the full amortization of the fair value adjustment in purchase accounting for inventory.

Research and development expenses were $30.4 million for the nine months ended September 30, 2016 compared to $23.3 million for the nine months ended September 30, 2015, an increase of $7.0 million or 30.1%, of which $8.4 million relates to our Chemical segment. 

Selling, general, and administrative expenses were $135.8 million for the nine months ended September 30, 2016 compared to $77.5 million for the nine months ended September 30, 2015, an increase of $58.4 million or 75.3%, of which $53.2 million relates to our Chemical segment.

Interest expense, net was $101.5 million for the nine months ended September 30, 2016 compared to $18.0 million for the nine months ended September 30, 2015, an increase of $83.5 million. The increase is primarily due to additional indebtedness related to the Arizona Chemical Acquisition.

Income tax benefit was $83.0 million and income tax expense was $4.1 million for the nine months ended September 30, 2016 and 2015, respectively. Following the completion of the Arizona Chemical Acquisition, we reassessed the need for a valuation allowance against our U.S. net operating loss deferred tax assets and released $86.6 million of the previously recorded valuation allowance.

Net income attributable to Kraton was $111.0 million or $3.56 per diluted share for the nine months ended September 30, 2016, an increase of $117.6 million compared to net loss of $6.6 million or $0.21 per diluted share for the nine months ended September 30, 2015. Adjusted earnings per diluted share (non-GAAP) was $2.07 for the nine months ended September 30, 2016 compared to $1.26 for the nine months ended September 30, 2015. See a reconciliation of GAAP earnings (loss) per diluted share to non-GAAP adjusted earnings per diluted share below.

Polymer Segment



Three Months Ended September 30,



Nine Months Ended September 30,



2016



2015



2016



2015

Revenue

(In thousands)



(In thousands)

Cariflex

$

45,303





$

34,044





$

126,513





$

102,069



Specialty Polymers

89,107





86,828





256,197





263,082



Performance Products

138,479





147,987





403,214





420,889



Other

81





153





208





309





$

272,970





$

269,012





$

786,132





$

786,349



















Operating income

$

28,728





$

17,151





$

59,936





$

14,122



Adjusted EBITDA (non-GAAP) (1)

$

49,576





$

42,393





$

141,023





$

116,773





__________________________________

(1)

See Non-GAAP reconciliations included in the accompanying financial tables for the reconciliation of each non-GAAP measure to its most directly comparable GAAP measure.

 

Q3 2016 VERSUS Q3 2015 RESULTS

Revenue for the Polymer segment was $273.0 million for the three months ended September 30, 2016 compared to $269.0 million for the three months ended September 30, 2015, an increase of $4.0 million or 1.5%. The increase was due to higher sales volumes of $23.2 million and changes in foreign currency exchange rates of $3.8 million, partially offset by lower average selling prices amounting to $23.0 million, which were primarily driven by lower average raw material costs, lower prices for certain SIS product grades and mix. Sales volumes were 85.9 kilotons for the three months ended September 30, 2016, an increase of 5.0 kilotons or 6.1%. 

With respect to revenue for the Polymer segment product groups:

  • Cariflex revenue was $45.3 million for the three months ended September 30, 2016 compared to $34.0 million for the three months ended September 30, 2015. The increase of $11.3 million was attributable to a 29.4% increase in sales volumes, primarily into surgical glove applications, and changes in foreign currency exchange rates amounting to $2.4 million.
  • Specialty Polymers revenue was $89.1 million for the three months ended September 30, 2016 compared to $86.8 million for the three months ended September 30, 2015, a $2.3 million increase, which includes a decrease of $1.7 million related to the sale of the Belpre Compounding Unit ("BCU"). The revenue increase was attributable to a 10.2% increase in sales volumes, primarily within automotive and lubricant additive applications, partially offset by lower average selling prices resulting from lower raw material costs.
  • Performance Products revenue was $138.5 million for the three months ended September 30, 2016 compared to $148.0 million for the three months ended September 30, 2015. The $9.5 million decline was primarily driven by lower average selling prices due to lower raw material costs, lower prices for certain SIS product grades reflective of global over capacity for SIS, and product mix, partially offset by a 3.2% increase in sales volumes and changes in foreign currency exchange rates of $1.1 million. The increase in sales volumes was primarily driven by higher sales into roofing and personal care applications, which more than offset lower volume into paving applications and lower sales of SIS product grades into packaging and industrial adhesive applications. A factor in the decline in paving volume was constrained availability of butadiene arising from a cracker outage from one of our suppliers.

For the three months ended September 30, 2016, the Polymer segment operating income was $28.7 million compared to $17.2 million for the three months ended September 30, 2015.

For the three months ended September 30, 2016, the Polymer segment generated Adjusted EBITDA (non-GAAP) of $49.6 million compared to $42.4 million for the three months ended September 30, 2015, an increase of $7.2 million, or 16.9%.  The increase was due to higher sales volumes and lower costs, partially offset by modestly lower unit margins, including the effect of product mix. The effect of currency fluctuations negatively impacted Adjusted EBITDA (non-GAAP) by $2.2 million. See a reconciliation of GAAP operating income to non-GAAP Adjusted EBITDA below.

YTD 2016 VERSUS YTD 2015 RESULTS

Revenue for the Polymer segment was $786.1 million for the nine months ended September 30, 2016 compared to $786.3 million for the nine months ended September 30, 2015. Lower average selling prices amounting to $76.5 million, primarily driven by lower average raw material costs, lower prices for certain SIS product grades and mix, was offset by an increase of $74.4 million due to higher sales volumes and changes in foreign currency exchange rates of $2.0 million. Sales volumes were 250.9 kilotons for the nine months ended September 30, 2016, an increase of 19.3 kilotons or 8.3%.

With respect to revenue for the Polymer segment product groups:

  • Cariflex revenue was $126.5 million for the nine months ended September 30, 2016 compared to $102.1 million for the nine months ended September 30, 2015. The increase of $24.4 million was attributable to a 23.7% increase in sales volumes, primarily due to higher sales into surgical glove applications, and changes in foreign currency of $4.1 million, partially offset by a $4.2 million decrease attributable to lower average selling prices resulting from lower raw material costs.
  • Specialty Polymers revenue was $256.2 million for the nine months ended September 30, 2016 compared to $263.1 million for the nine months ended September 30, 2015, a decrease of $6.9 million. Excluding the $7.8 million effect of the sale of the BCU, which occurred in the first quarter of 2016, revenue was essentially unchanged with a 7.2% increase in sales volumes, largely in automotive and industrial applications, offset by lower average selling prices due to lower raw material costs and a $1.0 million negative effect from changes in currency exchange rates.
  • Performance Products revenue was $403.2 million for the nine months ended September 30, 2016 compared to $420.9 million for the nine months ended September 30, 2015. The $17.7 million decrease was primarily driven by lower average selling prices resulting from lower raw material costs, lower prices for certain SIS product grades and mix, and changes in foreign currency exchange rates of $1.2 million, partially offset by 7.5% increase in sales volumes. The increase in sales volumes was primarily driven by paving, roofing, and personal care applications, partially offset by lower sales of SIS product grades into packaging and industrial adhesive applications.

For the nine months ended September 30, 2016, the Polymer segment operating income was $59.9 million compared to $14.1 million for the nine months ended September 30, 2015.

For the nine months ended September 30, 2016, the Polymer segment generated $141.0 million of Adjusted EBITDA (non-GAAP) compared to $116.8 million for the nine months ended September 30, 2015, an increase $24.3 million or 20.8%.  The increase was a result of higher sales volumes and lower costs, partially offset by lower unit margins, including the effect of product mix. The effect of currency fluctuations negatively impacted Adjusted EBITDA (non-GAAP) by $4.9 million. See a reconciliation of GAAP operating income to non-GAAP Adjusted EBITDA below.

Chemical Segment

The results for the Chemical segment are included in the consolidated financial statements for the period January 6, 2016 to September 30, 2016. The 2015 amounts have been derived from the Arizona Chemical historical operating results and are being included for comparative purposes only. 



Three Months Ended

September 30, 2016



Three Months Ended

September 30, 2015



For the period January

6, 2016 through

September 30, 2016



Nine Months Ended

September 30, 2015

Revenue

(In thousands)

Adhesives

$

60,771





$

65,754





$

186,903





$

205,250



Roads and construction

13,778





16,138





40,845





41,864



Tires

10,380





11,058





30,238





32,058



Chemical intermediates

96,244





114,531





284,597





341,791





$

181,173





$

207,481





$

542,583





$

620,963



 

Q3 2016 VERSUS Q3 2015 RESULTS

Revenue for the Chemical segment was $181.2 million for the three months ended September 30, 2016 compared to $207.5 million for the three months ended September 30, 2015, a decrease of $26.3 million or 12.7%. Sales volumes were 104.3 kilotons for the three months ended September 30, 2016 compared to 104.8 kilotons for the three months ended September 30, 2015, a decrease of 0.5 kilotons or 0.4%.

With respect to revenue for the Chemical segment product groups:

  • Adhesives revenue was $60.8 million for the three months ended September 30, 2016 compared to $65.8 million for the three months ended September 30, 2015, a decrease of $5.0 million or 7.6%, largely due to lower average selling prices due to the availability of low cost hydrocarbon C5 based alternatives, which has resulted in price pressures. This was partially offset by higher sales volume of 2.4%. 
  • Roads and Construction revenue was $13.8 million for the three months ended September 30, 2016 compared to $16.1 million for the three months ended September 30, 2015, an decrease of $2.4 million or 14.6%, primarily attributable to lower average selling prices.
  • Tires revenue was $10.4 million for the three months ended September 30, 2016, effectively unchanged compared to $11.1 million for the three months ended September 30, 2015.
  • Chemical Intermediates revenue was $96.2 million for the three months ended September 30, 2016 compared to $114.5 million for the three months ended September 30, 2015, a decrease of $18.3 million, or 16.0%. The revenue decline reflects lower average selling prices, driven by excess supply of tall oil fatty acids ("TOFA") and tall oil rosin ("TOR"), and to a lesser extent, a 1.3% decrease in sales volume.

For the three months ended September 30, 2016, the Chemical segment operating income was $22.1 million.  

For the three months ended September 30, 2016, the Chemical segment generated Adjusted EBITDA (non-GAAP) of $41.5 million. See a reconciliation of GAAP operating income to non-GAAP Adjusted EBITDA below.

YTD 2016 VERSUS YTD 2015 RESULTS

Revenue for the Chemical segment was $542.6 million from the date of the Arizona Chemical Acquisition to September 30, 2016 compared to $621.0 million for the nine months ended September 30, 2015, a decrease of $78.4 million, or 12.6%. Sales volumes were 308.0 kilotons for the period from January 6, 2016 through September 30, 2016 compared to 315.4 kilotons for the nine months ended September 30, 2015, a decrease of 7.4 kilotons or 2.3%.

With respect to revenue for the Chemical segment product groups:

  • Adhesives revenue was $186.9 million from the date of the Arizona Chemical Acquisition to September 30, 2016 compared to $205.3 million for the nine months ended September 30, 2015, a decrease of $18.3 million or 8.9%, largely due to lower average selling prices and to a lesser degree lower sales volume of 3.0%. The availability of low cost hydrocarbon C5 based alternatives has resulted in price pressures in adhesive markets.
  • Roads and Construction revenue was $40.8 million from the date of the Arizona Chemical Acquisition to September 30, 2016 compared to $41.9 million for the nine months ended September 30, 2015, an decrease of $1.0 million or 2.4%, primarily attributable to lower average selling prices, which were partially offset by a 4.7% increase in sales volume.
  • Tires revenue was $30.2 million, compared to $32.1 million for the nine months ended September 30, 2015, a decrease of $1.8 million or 5.7%, primarily attributable to a to lower average selling prices.
  • Chemical Intermediates revenue was $284.6 million from the date of the Arizona Chemical Acquisition to September 30, 2016 compared to $341.8 million for the nine months ended September 30, 2015, a decrease of $57.2 million or 16.7%. The revenue decline reflects lower average selling prices, driven by excess supply of TOFA and TOR and lower substitute material pricing, and to a lesser extent, a 2.8% decrease in sales volume.

From the date of the Arizona Chemical Acquisition to September 30, 2016, the Chemical segment operating income was $40.9 million.  

From the date of the Arizona Chemical Acquisition to September 30, 2016, the Chemical segment generated Adjusted EBITDA (non-GAAP) of $135.9 million. See a reconciliation of GAAP operating income to non-GAAP Adjusted EBITDA below.

CASH FLOW AND CAPITAL STRUCTURE

In connection with the Arizona Chemical Acquisition, we entered into a $1,350.0 million six-year senior secured first lien term loan facility and issued $440.0 million in aggregate principal amount of 10.5% senior notes due 2023. In addition, we entered into a $250.0 million five-year asset-based revolving credit facility, we did not have any borrowings drawn under this facility as of September 30, 2016. We applied a portion of the acquisition-related proceeds to prepay our previously issued 6.75% Senior Notes ($350.0 million principal amount plus fees and expenses of $8.0 million) and fund $57.6 million of debt issuance costs. 

Since the date of the Arizona Chemical Acquisition (excluding borrowings under the KFPC Loan Agreement) we repaid approximately $109 million of Kraton Corporation indebtedness, while increasing cash on hand (excluding KFPC cash) by approximately $37 million.

Summary of principal amounts for indebtedness and net debt:



As of September 30, 2016



As of January 6, 2016



(In thousands)

Term Loan

$

1,278,000





$

1,350,000



10.5% Senior Notes

440,000





440,000



ABL





37,075



Capital lease

1,529





1,634



Kraton debt

1,719,529





1,828,709



Kraton cash

134,755





97,400



Kraton net debt

1,584,774





1,731,309











KFPC(1) loan

106,128





76,912



KFPC(1) cash

8,793





9,315



KFPC(1) net debt

97,335





67,597











Consolidated net debt

$

1,682,109





$

1,798,906





______________________________________

(1)

Represents the debt of Kraton Formosa Polymers Corporation (KFPC) located in Mailiao, Taiwan, a 50% investment in a joint venture,which we consolidate.

 

OUTLOOK

Our third quarter 2016 results were below our expectations primarily due to weaker than anticipated margins and volumes for sales into adhesive applications in both our Polymer and Chemical segments, lower prices for TOFA and TOR products, and lower sales of SBS products.  In light of the year-to-date results and the expectation that market conditions will not reverse in the fourth quarter, we now expect fourth quarter 2016 Adjusted EBITDA to be in the low $80 million range, resulting in full-year 2016 Adjusted EBITDA of approximately $360 million.

We expect Kraton net debt to be approximately $1.6 billion at December 31, 2016, and we remain committed to our goal of delivering a $500 million reduction in Kraton net debt by December 31, 2018.  

We currently estimate that our results in the fourth quarter 2016 will reflect a positive spread between FIFO and ECRC of approximately $5.0 million.

We have not reconciled Adjusted EBITDA guidance to net income (loss) because we do not provide guidance for net income (loss) or for items that we do not consider indicative of our on-going performance, including, but not limited to, transaction and acquisition costs and costs associated with dispositions, business exits, and production downtime, as certain of these items are out of our control and/or cannot be reasonably predicted. Accordingly, a reconciliation of the non-GAAP financial measure guidance to the corresponding GAAP measures is not available without unreasonable effort.

USE OF NON-GAAP FINANCIAL MEASURES

This press release includes the use of both GAAP and non-GAAP financial measures. The non-GAAP financial measures are EBITDA, Adjusted EBITDA, and Adjusted Net Income attributable to Kraton (or earnings per share). Tables included in this earnings release reconcile each of these non-GAAP financial measures with the most directly comparable GAAP financial measure.  For additional information on the impact of the spread between the FIFO basis of accounting and estimated current replacement cost ("ECRC"), see Management's Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended December 31, 2015.

We consider these non-GAAP financial measures to be important supplemental measures of our performance and believe they are frequently used by investors, securities analysts and other interested parties in the evaluation of our performance including period-to-period comparisons and/or that of other companies in our industry. Further, management uses these measures to evaluate operating performance, and our incentive compensation plan bases incentive compensation payments on our Adjusted EBITDA performance, along with other factors. These non-GAAP financial measures have limitations as analytical tools and in some cases can vary substantially from other measures of our performance. You should not consider them in isolation, or as a substitute for analysis of our results under GAAP in the United States. For EBITDA, which represents net income before interest, taxes, depreciation and amortization, these limitations include: EBITDA does not reflect the significant interest expense on our debt; EBITDA does not reflect the significant depreciation and amortization expense associated with our long-lived assets; and EBITDA included herein should not be used for purposes of assessing compliance or non-compliance with financial covenants under our debt agreements. The calculation of EBITDA in our debt agreements includes adjustments, such as extraordinary, non-recurring or one-time charges, proforma cost savings, certain non-cash items, turnaround costs, and other items included in the definition of EBITDA in the debt agreements. Other companies in our industry may calculate EBITDA differently than we do, limiting its usefulness as a comparative measure. As an analytical tool, Adjusted EBITDA is subject to all the limitations applicable to EBITDA. We prepare Adjusted EBITDA by eliminating from EBITDA the impact of a number of items we do not consider indicative of our on-going performance, including the spread between FIFO and ECRC, but you should be aware that in the future we may incur expenses similar to the adjustments in this presentation. Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. In addition, due to volatility in raw material prices, Adjusted EBITDA may, and often does, vary substantially from EBITDA and other performance measures, including net income calculated in accordance with U.S. GAAP; and Adjusted EBITDA may, and often will, vary significantly from EBITDA calculations under the terms of our debt agreements and should not be used for assessing compliance or non-compliance with financial covenants under our debt agreements. Because of these and other limitations, EBITDA and Adjusted EBITDA should not be considered as a measure of discretionary cash available to us to invest in the growth of our business. Finally, we prepare Adjusted Net Income attributable to Kraton by eliminating from net income (loss) the impact of a number of items we do not consider indicative of our on-going performance, including the spread between FIFO and ECRC. Our presentation of non-GAAP financial measures and the adjustments made therein should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items, and in the future we may incur expenses or charges similar to the adjustments made in the presentation of our non-GAAP financial measures.

CONFERENCE CALL AND WEBCAST INFORMATION

Kraton has scheduled a conference call on Thursday, October 27, 2016 at 9:00 a.m. (Eastern Time) to discuss third quarter 2016 financial results. Kraton invites you to listen to the conference call, which will be broadcast live over the internet at www.kraton.com, by selecting the "Investor Relations" link at the top of the home page and then selecting "Events" from the Investor Relations menu on the Investor Relations page.

You may also listen to the conference call by telephone by contacting the conference call operator 5 to 10 minutes prior to the scheduled start time and asking for the "Kraton Conference Call – Passcode: Earnings Call." U.S./Canada dial-in 800-857-6511. International dial-in #: 210-839-8886.

For those unable to listen to the live call, a replay will be available beginning at approximately 11:00 a.m. (Eastern Time) on October 27, 2016 through 1:59 a.m. (Eastern Time) on November 11, 2016. To hear a replay of the call over the Internet, access Kraton's Website at www.kraton.com by selecting the "Investor Relations" link at the top of the home page and then selecting "Events" from the Investor Relations menu on the Investor Relations page. To hear a telephonic replay of the call, dial 866-516-0665.

ABOUT KRATON

Kraton Corporation (NYSE "KRA") is a leading global producer of styrenic block copolymers, specialty polymers and high-value performance products derived from renewable sources.  Kraton's polymers are used in a wide range of applications, including adhesives, coatings, consumer and personal care products, sealants and lubricants, and medical, packaging, automotive, paving and roofing applications. As the largest global provider in the pine chemicals industry, the company's pine-based specialty products are sold into adhesive, road and construction and tire markets, and it produces and sells a broad range of chemical intermediates into markets that include fuel additives, oilfield chemicals, coatings, metalworking fluids and lubricants, inks, flavors and fragrances and mining. Kraton offers its products to a diverse customer base in numerous countries worldwide.

Kraton, the Kraton logo and design, and Cariflex are all trademarks of Kraton Polymers LLC.

FORWARD LOOKING STATEMENTS

Some of the statements in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. This press release includes forward-looking statements that reflect our plans, beliefs, expectations, and current views with respect to, among other things, future events and financial performance. Forward-looking statements are often characterized by the use of words such as "outlook," "believes," "estimates," "expects," "projects," "may," "intends," "plans", "on track", or "anticipates," or by discussions of strategy, plans or intentions, including all matters described on the section titled "Outlook" including, but not limited to, our outlook for full year 2016 guidance for Adjusted EBITDA, expectations of Kraton net debt at December 31, 2016 and December 31, 2018 and fourth quarter 2016 guidance on the positive spread between FIFO and ECRC.

All forward-looking statements in this press release are made based on management's current expectations and estimates, which involve known and unknown risks, uncertainties, and other important factors that could cause actual results to differ materially from those expressed in forward-looking statements. These risks and uncertainties are more fully described in our latest Annual Report on Form 10-K, including but not limited to "Part I, Item 1A. Risk Factors" and "Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations" therein, and in our other filings with the Securities and Exchange Commission, and include, but are not limited to, risks related to: the integration of Arizona Chemical (now, AZ Chem Holdings LP); Kraton's ability to repay its indebtedness; Kraton's reliance on third parties for the provision of significant operating and other services; conditions in the global economy and capital markets; fluctuations in raw material costs; limitations in the availability of raw materials; competition in Kraton's end-use markets; and other factors of which we are currently unaware or deem immaterial.  Readers are cautioned not to place undue reliance on our forward-looking statements. Forward-looking statements speak only as of the date they are made, and we assume no obligation to update such information in light of new information or future events.

For Further Information:

H. Gene Shiels

Director of Investor Relations

(281) 504-4886

 

KRATON CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(In thousands, except per share data)





Three Months Ended September 30,



Nine Months Ended September 30,



2016



2015



2016



2015

Revenue

$

454,143





$

269,012





$

1,328,715





$

786,349



Cost of goods sold

318,887





201,202





967,744





624,542



Gross profit

135,256





67,810





360,971





161,807



Operating expenses:















Research and development

9,693





7,597





30,383





23,345



Selling, general, and administrative

42,769





26,917





135,845





77,488



Depreciation and amortization

31,977





16,145





93,913





46,852



Operating income

50,817





17,151





100,830





14,122



Disposition and exit of business activities









40,001







Loss on extinguishment of debt









(13,423)







Earnings of unconsolidated joint venture

94





95





274





273



Interest expense, net

(33,870)





(6,151)





(101,450)





(17,975)



Income (loss) before income taxes

17,041





11,095





26,232





(3,580)



Income tax benefit (expense)

(2,198)





(3,076)





83,024





(4,135)



Consolidated net income (loss)

14,843





8,019





109,256





(7,715)



Net loss attributable to noncontrolling interest

717





427





1,792





1,141



Net income (loss) attributable to Kraton

$

15,560





$

8,446





$

111,048





$

(6,574)



Earnings (loss) per common share:















Basic

$

0.50





$

0.27





$

3.60





$

(0.21)



Diluted

$

0.49





$

0.27





$

3.56





$

(0.21)



Weighted average common shares outstanding:















Basic

30,221





30,503





30,137





30,779



Diluted

30,783





30,849





30,557





30,779



 

KRATON CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except par value)





September 30, 2016



December 31, 2015



(unaudited)





ASSETS







Current assets:







Cash and cash equivalents

$

143,548





$

70,049



Receivables, net of allowances of $847 and $244

209,867





105,089



Inventories of products

321,845





264,107



Inventories of materials and supplies

20,717





12,138



Other current assets

68,134





29,956



Total current assets

764,111





481,339



Property, plant, and equipment, less accumulated depreciation of $420,907 and $382,157

905,117





517,673



Goodwill

753,928







Intangible assets, less accumulated amortization of $135,361 and $100,093

451,576





41,602



Investment in unconsolidated joint venture

11,608





11,628



Debt issuance costs

3,803





1,337



Deferred income taxes

5,218





3,867



Other long-term assets

23,332





21,789



Total assets

$

2,918,693





$

1,079,235



LIABILITIES AND EQUITY







Current liabilities:







Current portion of long-term debt

$

23,135





$

141



Accounts payable-trade

134,560





59,337



Other payables and accruals

157,330





91,011



Due to related party

14,907





14,101



Total current liabilities

329,932





164,590



Long-term debt, net of current portion

1,698,952





415,591



Deferred income taxes

213,776





9,070



Other long-term liabilities

141,305





96,992



Total liabilities

2,383,965





686,243











Equity:







Kraton stockholders' equity:







Preferred stock, $0.01 par value; 100,000 shares authorized; none issued







Common stock, $0.01 par value; 500,000 shares authorized; 30,916 shares issued and outstanding at September 30, 2016; 30,569 shares issued and outstanding at December 31, 2015

309





306



Additional paid in capital

358,798





349,871



Retained earnings

258,179





147,131



Accumulated other comprehensive loss

(116,611)





(138,568)



Total Kraton stockholders' equity

500,675





358,740



Noncontrolling interest

34,053





34,252



Total equity

534,728





392,992



Total liabilities and equity

$

2,918,693





$

1,079,235



 



KRATON CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)





Nine Months Ended September 30,



2016



2015

CASH FLOWS FROM OPERATING ACTIVITIES







Consolidated net income (loss)

$

109,256





$

(7,715)



Adjustments to reconcile consolidated net income (loss) to net cash provided by operating activities:







Depreciation and amortization

93,913





46,852



Amortization of debt premium and original issue discount

4,893





(130)



Amortization of debt issuance costs

5,343





1,668



(Gain) loss on disposal of property, plant, and equipment

452





(60)



Disposition and exit of business activities

(40,001)







Loss on extinguishment of debt

13,423







Earnings from unconsolidated joint venture, net of dividends received

136





90



Deferred income tax benefit

(4,343)





(2,270)



Release of valuation allowance

(86,631)







Share-based compensation

7,272





6,601



Decrease (increase) in:







Accounts receivable

(18,114)





(9,693)



Inventories of products, materials, and supplies

44,035





50,462



Other assets

(3,044)





(2,022)



Increase (decrease) in:







Accounts payable-trade

(2,981)





(2,988)



Other payables and accruals

(401)





1,548



Other long-term liabilities

4,631





1,536



Due to related party

(1,710)





(2,306)



Net cash provided by operating activities

126,129





81,573



CASH FLOWS FROM INVESTING ACTIVITIES







Kraton purchase of property, plant, and equipment

(62,885)





(42,384)



KFPC purchase of property, plant, and equipment

(16,995)





(46,097)



Purchase of software and other intangibles

(4,691)





(1,763)



Acquisition, net of cash acquired

(1,312,105)







Sale of assets

72,803







Net cash used in investing activities

(1,323,873)





(90,244)



CASH FLOWS FROM FINANCING ACTIVITIES







Proceeds from debt

1,782,965





30,000



Repayments of debt

(480,133)





(30,000)



KFPC proceeds from debt

24,368





55,622



Capital lease payments

(105)





(99)



Purchase of treasury stock

(967)





(31,891)



Proceeds from the exercise of stock options

2,625





1,022



Settlement of interest rate swap

(5,155)







Debt issuance costs

(57,646)







Net cash provided by financing activities

1,265,952





24,654



Effect of exchange rate differences on cash

5,291





(6,002)



Net increase in cash and cash equivalents

73,499





9,981



Cash and cash equivalents, beginning of period

70,049





53,818



Cash and cash equivalents, end of period

$

143,548





$

63,799



Supplemental disclosures:







Cash paid during the period for income taxes, net of refunds received

$

7,788





$

5,435



Cash paid during the period for interest, net of capitalized interest

$

56,972





$

21,690



Capitalized interest

$

4,022





$

3,342



Supplemental non-cash disclosures:







Property, plant, and equipment accruals

$

30,494





$

16,023



Asset acquired through capital lease

$





$

681



 

RECONCILIATION OF GROSS PROFIT TO ADJUSTED GROSS PROFIT

(Unaudited)

(In thousands)











Three Months Ended September 30, 2016



Three Months Ended September 30, 2015



Polymer



Chemical



Total



Polymer



Chemical



Total



(In thousands)

Gross profit

$

77,008





$

58,248





$

135,256





$

67,810









$

67,810



























Add (deduct):























Restructuring and other charges (a)

743





8





751





61









61



Production downtime (b)













(146)









(146)



Non-cash compensation expense

128









128





122









122



Spread between FIFO and ECRC

(5,001)





1,879





(3,122)





926









926



Adjusted gross profit (non-GAAP)

$

72,878





$

60,135





$

133,013





$

68,773





$





$

68,773





















































___________________________________________

(a)   

Severance expenses and other restructuring related charges.





(b)   

In 2015, the reduction in costs is due to additional insurance recovery related to the Belpre, Ohio, production downtime.

 



Nine Months Ended September 30, 2016



Nine Months Ended September 30, 2015



Polymer



Chemical



Total



Polymer



Chemical



Total



(In thousands)

Gross profit

$

209,774





$

151,197





$

360,971





$

161,807









$

161,807



























Add (deduct):























Restructuring and other charges (a)

785





8





793





142









142



Effect of purchase price accounting on inventory valuation (b)





24,719





24,719















Production downtime (c)













(474)









(474)



Non-cash compensation expense

436









436





396









396



Spread between FIFO and ECRC

5,807





13,788





19,595





40,144









40,144



Adjusted gross profit (non-GAAP)

$

216,802





$

189,712





$

406,514





$

202,015





$





$

202,015





















































______________________________________

(a)  

Severance expenses and other restructuring related charges.





(b)   

Higher costs of goods sold for our Chemical segment related to the fair value adjustment in purchase accounting for their inventory.





(c)   

In 2015, the reduction in costs is due to additional insurance recovery related to the Belpre, Ohio, production downtime.

 



KRATON CORPORATION

RECONCILIATION OF NET INCOME ATTRIBUTABLE TO KRATON AND OPERATING INCOME TO NON-GAAP FINANCIAL MEASURES

(Unaudited)

(In thousands)











Three Months Ended September 30, 2016



Three Months Ended September 30, 2015



Polymer



Chemical



Total



Polymer



Chemical



Total



(In thousands)

Net income attributable to Kraton









$

15,560













$

8,446



Net loss attributable to noncontrolling interest









(717)













(427)



Consolidated net income









14,843













8,019



Add (deduct):























Income tax expense









2,198













3,076



Interest expense, net









33,870













6,151



Earnings of unconsolidated joint venture









(94)













(95)



Operating income

$

28,728





$

22,089





$

50,817





$

17,151





$





$

17,151



Add:























Depreciation and amortization

14,977





17,000





31,977





16,145









16,145



Earnings of unconsolidated joint venture

94









94





95









95



EBITDA

43,799





39,089





82,888





33,391









33,391



Add (deduct):























Transaction, acquisition related costs, restructuring, and other costs (a)

7,216





530





7,746





5,501









5,501



Production downtime (b)













(134)









(134)



KFPC startup costs (c)

1,421









1,421





677









677



Non-cash compensation expense (d)

2,141









2,141





2,032









2,032



Spread between FIFO and ECRC

(5,001)





1,879





(3,122)





926









926



Adjusted EBITDA

$

49,576





$

41,498





$

91,074





$

42,393





$





$

42,393







__________________________________

(a)   

Charges related to the evaluation of acquisition transactions, severance expenses, and other restructuring related charges, which are primarily recorded in selling, general, and administrative expenses.





(b)   

In 2015, the reduction in costs is due to additional insurance recovery related to the Belpre, Ohio, production downtime, which is primarily recorded in cost of goods sold.





(c)   

Startup costs related to the joint venture company, KFPC, which are recorded in selling, general, and administrative expenses.





(d)   

For the three months ended September 30, 2016 and 2015, respectively, $1.9 million and $1.7 million is recorded in selling, general and administrative expenses, $0.1 million and $0.2 million is recorded in research and development expenses, and $0.1 million and $0.1 million is recorded in cost of goods sold.

 

KRATON CORPORATION

RECONCILIATION OF NET INCOME (LOSS) ATTRIBUTABLE TO KRATON AND OPERATING INCOME TO NON-GAAP FINANCIAL MEASURES

(Unaudited)

(In thousands)











Nine Months Ended September 30, 2016



Nine Months Ended September 30, 2015



Polymer



Chemical



Total



Polymer



Chemical



Total



(In thousands)

Net income (loss) attributable to Kraton









$

111,048













$

(6,574)



Net loss attributable to noncontrolling interest









(1,792)













(1,141)



Consolidated net income (loss)









109,256













(7,715)



Add (deduct):























Income tax (benefit) expense









(83,024)













4,135



Interest expense, net









101,450













17,975



Earnings of unconsolidated joint venture









(274)













(273)



Loss on extinguishment of debt









13,423















Disposition and exit of business activities









(40,001)















Operating income

$

59,936





$

40,894





$

100,830





$

14,122





$





$

14,122



Add (deduct):























Depreciation and amortization

45,199





48,714





93,913





46,852









46,852



Disposition and exit of business activities

40,001









40,001















Loss on extinguishment of debt

(13,423)









(13,423)















Earnings of unconsolidated joint venture

274









274





273









273



EBITDA

131,987





89,608





221,595





61,247









61,247



Add (deduct):























Transaction, acquisition related costs, restructuring, and other costs (a)

19,255





7,773





27,028





7,297









7,297



Disposition and exit of business activities

(40,001)









(40,001)















Loss on extinguishment of debt

13,423









13,423















Effect of purchase price accounting on inventory valuation





24,719





24,719















Production downtime (b)













(343)









(343)



KFPC startup costs (c)

3,280









3,280





1,827









1,827



Non-cash compensation expense (d)

7,272









7,272





6,601









6,601



Spread between FIFO and ECRC

5,807





13,788





19,595





40,144









40,144



Adjusted EBITDA

$

141,023





$

135,888





$

276,911





$

116,773





$





$

116,773







__________________________________

(a)   

Charges related to the evaluation of acquisition transactions, severance expenses, and other restructuring related charges, which are primarily recorded in selling, general, and administrative expenses.





(b)   

In 2015, the reduction in costs is due to additional insurance recovery related to the Belpre, Ohio, production downtime, which is primarily recorded in cost of goods sold.





(c)   

Startup costs related to the joint venture company, KFPC, which are recorded in selling, general, and administrative expenses.





(d)    

For the nine months ended September 30, 2016 and 2015, respectively, $6.3 million and $5.7 million is recorded in selling, general and administrative expenses, $0.6 million and $0.5 million is recorded in research and development expenses, and $0.4 million and $0.4 million is recorded in cost of goods sold.

 



We reconcile Earnings (Loss) Per Diluted Share to Adjusted Earnings Per Diluted Share (non-GAAP) as follows:



Three Months Ended

September 30,



Nine Months Ended

September 30,



2016



2015



2016



2015

Earnings (Loss) Per Diluted Share

$

0.49





$

0.27





$

3.56





$

(0.21)



Transaction, acquisition related costs, restructuring, and other costs (a)

0.20





0.18





0.72





0.23



Disposition and exit of business activities









(0.82)







Loss on extinguishment of debt









0.28







Production downtime (b)





(0.01)









(0.01)



Effect of purchase price accounting on inventory valuation (c)









0.63







KFPC startup costs (d)

0.02





0.01





0.04





0.02



Valuation Allowance (e)









(2.77)







Spread between FIFO and ECRC

(0.08)





0.03





0.43





1.23



Adjusted Earnings Per Diluted Share (non-GAAP)

$

0.63





$

0.48





$

2.07





$

1.26







__________________________________

(a)  

Charges related to the evaluation of acquisition transactions, severance expenses, and other restructuring related charges which are primarily recorded in selling, general, and administrative expenses.





(b)  

In 2015, the reduction in costs is due to additional insurance recovery related to the Belpre, Ohio, production downtime, which is primarily recorded in cost of goods sold.





(c)   

 Higher costs of goods sold for our Chemical segment related to the fair value adjustment in purchase accounting for their inventory.





(d)   

Startup costs related to the joint venture company, KFPC, which are recorded in selling, general and administrative expenses.





(e)   

Reduction of income tax valuation allowance related to the assessment of our ability to utilize net operating losses in future periods.

 

Logo - http://photos.prnewswire.com/prnh/20100728/DA42514LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/kraton-corporation-announces-third-quarter-2016-results-300352084.html

SOURCE Kraton Corporation

Weitere Themen